Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06967662) titled 'Selective Plasma Adsorption of Extracellular DNA in Prevention of Intraoperative Metastasis in Pancreatic Cancer (Pilot Study)' on May 3.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Investigator, Outcomes Assessor).
Primary Sponsor: Ilyinskaya Hospital, JSC
Condition:
Pancreatic Ductal Adenocarcinoma (PDAC)
Intervention:
Procedure: Selective plasma adsorption of extracellular DNA...
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: April 4, 2025
Target Sample Size: 28
Countries o...